Malin Corporation | MLC - Passivo Circulante





Passivo Circulante Alterar Data
Akebia Therapeutics USD 162.35M 1.48M 2026-09
Alaunos Therapeutics USD 864K 269K 2026-06
ALKERMES USD 651.93M 10.16M 2026-09
Avita Medical AUD 68.71M 6.04M 2026-06
Dianthus Therapeutics USD 28.51M 5.87M 2026-09
Eurofins Scientific SE EUR 2.49B 57M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
IQVIA Holdings USD 7.78B 1.04B 2026-09
Lonza CHF 3.57B 421M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
Moderna USD 2.53B 139M 2026-06
Organon & Co USD 2.65B 36M 2026-09
Ovoca Bio EUR 1.3M 1.11M 2025-12
Revvity USD 701.48M 574.88M 2026-09
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Viatris USD 6.64B 290.7M 2026-09
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06